MapLight Therapeutics Inc
MPLT
NASDAQ
Biotechnology
$11.75
USD
+0.17 (+1.47%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $519.09M
Volume 451.5K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q4 2025 | Q1 2026 |
|---|---|---|
Revenue | 0.0 | 0.0 |
YoY Growth | — | — |
Cost of Revenue | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 |
Selling, General & Administrative | 18.8 | 10.8 |
Other Operating Expenses | 0.0 | 0.0 |
Total Operating Expenses | 83.4 | 64.5 |
Operating Income | -83.4 | -64.5 |
EBITDA | -83.2 | -64.3 |
Other Income / Expense | 1.4 | 1.4 |
Total Other Income / Expense | 3.8 | 3.8 |
Income Before Income Taxes | -79.5 | -60.7 |
Income Taxes | 0.0 | 0.0 |
Net Income | -79.5 | -60.7 |
Consolidated Net Income / Loss | -79.5 | -60.7 |
Net Income Attributable to Common Shareholders | -79.5 | -60.7 |
Basic EPS | $0.00 | -$1.34 |
Diluted EPS | $0.00 | -$1.34 |
Basic Shares Outstanding | 0.0M | 45.3M |
Diluted Shares Outstanding | 0.0M | 45.3M |